Perella Weinberg Partners (PWP) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 17.89%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 17.89% | Share-based compensation / revenue. Period ending 2026-06-30. $123.31M ÷ $689.25M × 100 ≈ 17.89% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 689.25M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 123.31M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 19.55M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $689.25M | $123.31M | $19.55M | (m) | (m) | 17.89% | (m) | (m) |
| 2026-03-31 | (m) | $687.99M | $115.07M | $23.44M | (m) | (m) | 16.73% | (m) | (m) |
| 2025-12-31 | (m) | $750.90M | $110.50M | $48.01M | (m) | (m) | 14.71% | (m) | (m) |
| 2025-09-30 | (m) | $757.41M | $105.28M | $50.85M | (m) | (m) | 13.90% | (m) | (m) |
| 2025-06-30 | (m) | $871.01M | $106.09M | $77.88M | (m) | (m) | 12.18% | (m) | (m) |
| 2025-03-31 | (m) | $987.74M | $167.95M | $-13.30M | (m) | (m) | 17.00% | (m) | (m) |
| 2024-12-31 | (m) | $878.04M | $188.87M | $-78.53M | (m) | (m) | 21.51% | (m) | (m) |
| 2024-09-30 | (m) | $865.04M | $216.17M | $-143.87M | (m) | (m) | 24.99% | (m) | (m) |
| 2024-06-30 | (m) | $725.81M | $231.01M | $-206.45M | (m) | (m) | 31.83% | (m) | (m) |
| 2024-03-31 | (m) | $619.35M | $183.51M | $-145.97M | (m) | (m) | 29.63% | (m) | (m) |
| 2023-12-31 | (m) | $648.65M | $184.46M | $-115.10M | $276.00K | (m) | 28.44% | -417.03× | Reported |
| 2023-09-30 | (m) | $619.12M | $174.74M | $-90.68M | (m) | (m) | 28.22% | (m) | (m) |
| 2023-06-30 | (m) | $625.50M | $168.90M | $-72.80M | (m) | (m) | 27.00% | (m) | (m) |
| 2023-03-31 | (m) | $611.06M | $163.28M | $-60.06M | (m) | (m) | 26.72% | (m) | (m) |
| 2022-12-31 | (m) | $631.51M | $156.42M | $-47.73M | $276.00K | (m) | 24.77% | -172.95× | Reported |
| 2022-09-30 | (m) | $647.27M | $161.55M | $-28.81M | $276.00K | (m) | 24.96% | -104.38× | Reported |
| 2022-06-30 | (m) | $679.32M | $162.17M | $-30.32M | $279.00K | (m) | 23.87% | -108.67× | Reported |
| 2022-03-31 | (m) | $783.74M | $132.28M | $28.18M | $3.81M | (m) | 16.88% | 7.40× | Reported |
| 2021-12-31 | (m) | $801.66M | $97.03M | $66.58M | $7.61M | (m) | 12.10% | 8.75× | Reported |
| 2021-09-30 | (m) | (m) | (m) | $88.94M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | $100.80M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | $-1.88M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $-1.03M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | $-1.32K | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.